Category: Cirrhosis

All Podcast Categories
S4-15.3 - Session VIII: Stretch Exercise: New Look at Statistics

S4-15.3 – Session VIII: Stretch Exercise: New Look at Statistics

Co-hosts Jörn Schattenberg and Roger Green review the 2023 Liver Forum with Executive Director Veronica Miller and speakers Mazen Noureddin, Michelle Long and Jeff McIntyre. In this conversation, the group revisits a perspective-shifting session titled “A New Look at Statistics.”

S4-15.2 - Liver Forum 14: Panelists Select Sessions of Interest

S4-15.2 – Liver Forum 14: Panelists Select Sessions of Interest

Co-hosts Jörn Schattenberg and Roger Green review Liver Forum 14 with Executive Director Veronica Miller and speakers Mazen Noureddin, Michelle Long and Jeff McIntyre. For this conversation, each panelist picks a session that captured their interest and Mazen provides a flavor of his talk on Compensated Cirrhosis Risk Stratification.

S4-15.1 - What is The Liver Forum and Initial Impressions

S4-15.1 – What is The Liver Forum and Initial Impressions

Co-hosts Jörn Schattenberg and Roger Green review Liver Forum 14 with Executive Director Veronica Miller and speakers Mazen Noureddin, Michelle Long and Jeff McIntyre. In this conversation, Veronica recaps the aims of the Forum and each panelist shares their initial reactions around what makes the meeting special.

S4-15 - Review of Liver Forum 14

S4-15 – Review of Liver Forum 14

Co-hosts Jörn Schattenberg and Roger Green review the 2023 Liver Forum with Executive Director Veronica Miller. Joining the session are meeting speakers Mazen Noureddin, Michelle Long and Jeff McIntyre. The group highlights how the event embodies truly integrative thinking.

S4-14.3 - Drug Development News: Phase 3 Press Releases on the Horizon

S4-14.3 – Drug Development News: Phase 3 Press Releases on the Horizon

Co-hosts Jörn Schattenberg, Louise Campbell and Roger Green convene to discuss what’s happening for fatty liver so far in 2023 and moving into the second quarter. In this conversation, the group share thoughts around drug development and the possibility of new Phase 3 press releases on the imminent horizon. Co-hosts Jörn Schattenberg, Louise Campbell and Roger Green convene to discuss what’s happening for fatty liver so far in 2023 and moving into the second quarter. In this conversation, the group share thoughts around drug development and the possibility of new Phase 3 press releases on the imminent horizon.

S4-14.1 - Discussing the 3rd Annual Liver Connect Conference

S4-14.1 – Discussing the 3rd Annual Liver Connect Conference

Co-hosts Jörn Schattenberg, Louise Campbell and Roger Green convene to discuss what’s happening for fatty liver so far in 2023 and moving into the second quarter. In this conversation, Jörn describes his attendance at the 3rd Annual Liver Connect Conference in California.

S4-14 - Co-Host Roundtable on the Liver Connect Conference, FibroScan and Pathways, Therapeutic News and More

S4-14 – Co-Host Roundtable on the Liver Connect Conference, FibroScan and Pathways, Therapeutic News and More

This week, co-hosts Jörn Schattenberg, Louise Campbell and Roger Green discuss the 3rd Annual Liver Connect Conference, NICE approval process for FibroScan in primary care, updates in the therapeutic pipeline, pathways and the Surfing NASH 4th anniversary special. The session is fun and full of surprises – like a new metaphor from Roger to describe fatty liver disease.

S2-03 - Why Clinical Care Pathways Matter

S2-E3 – Why Clinical Care Pathways Matter

In this episode of the Rising Tide series, co-hosts Ken Cusi and Roger Green are joined by KOL in public health, Jeff Lazarus, and physician and associate professor of internal medicine, Jeff Budd. The panelists focus on why clinical care pathways matter and drive the message that primary care plays an integral role in fighting fatty liver.

Experience Nudge Learning! Interested in a new way of learning?